21 March 2023 in Traumatology and Orthopedics of Russia
ПИПутляев Валерий Иванович
+6
Background. The problem of bone defects replacement is relevant nowadays, that is why many scientists create new synthetic bone substitutes, but the ideal material has not been found so far. The aims of the study: 1) to determine the suitability of the monocortical defect model in the rat femur diaphysis with additional prophylactic reinforcement with a bone plate for assessing the biological properties of implanted materials using the commercially available ChronOS material as an example; 2) to assess of the osteoconductive properties of composite materials based on poly(ethylene glycol)diacrylate and octacalcium phosphate with architecture Kelvin and gyroid types on the developed model. Methods. A prospective study, level of evidence II. A monocortical defect of the rat femoral diaphysis (length 7 mm) was produced under anaesthesia in aseptic conditions and fixed with a polyetheretherketone plate and six titanium screws. In the control group, the defect was left empty. In other groups, blocks of one of three materials were implanted сhronOS and composites of poly(ethylene glycol)diacrylate and octacalcium phosphate with 3D-printed Kelvin and gyroid architectures. After 3 and 6 weeks, the rats were sacrificed, and histological examination of the defect zone was performed. The amount of newly formed bone tissue was histometricly assessed, followed by statistical processing of the results. Results. All rats have reached the planned endpoint, and there were no infectious complications or loss of fixation. Histological examination of the defect zone revealed minimal bone growth in the Control group, rather slow bone formation in the Gyroid group, and statistically significantly more pronounced bone formation in the pores of the materials in the Kelvin and Chronos groups. Conclusions. Bone defect in this model was not spontaneously filled with bone tissue and allowed us to study the biological properties of bone substitutes (the ability to biodegrade and osteoconductive properties). The osteoconductive properties of a composite material based on poly(ethylene glycol)diacrylate and octacalcium phosphate with a Kelvin architecture are higher than with a gyroid architecture and are comparable to that of the сhronOS.
8 December 2022 in Biological Products. Prevention, Diagnosis, Treatment
Finding effective and safe medicines to fight SARS-CoV-2 infection is an urgent task. RPH-137 is an original trap fusion protein against SARS-CoV-2 virus. It comprises the angiotensin-converting enzyme type 2 extracellular domain and the human IgG1 Fc fragment.The aim of the study was to carry out a preclinical evaluation of the efficacy of RPH-137 and molnupiravir against SARS-CoV-2 infection.Materials and methods: the authors analysed RPH-137 expressed in a stable CHO cell line and molnupiravir used as an active pharmaceutical ingredient. Drug-mediated inhibition of virus-induced cytotoxicity was assessed in Vero cell culture. In vivo efficacy assessments were performed in Syrian hamsters. The animals were infected intranasally with SARS-CoV-2 (PIK35 clinical isolate) in the dose of 5 log TCID50. The authors evaluated body weight measurements, lung–body weight ratios, and lung histopathology findings and determined viral RNA levels in oropharyngeal swabs by RT-PCR using the amplification cycle threshold (Ct). The statistical analyses involved one- and two-way ANOVA, Student's t-test, and Mann–Whitney test.Results: RPH-137 and molnupiravir inhibited the cytopathic effect of SARS-CoV-2 in Vero cells; the EC50 values of RPH-137 amounted to 4.69 μg/mL (21.3 nM) and 16.24 μg/mL (73.8 nM) for 50 TCID50 and 200 TCID50, respectively, whereas the EC50 values of molnupiravir were 0.63 μg/mL (1900 nM) for both doses. Intramuscular RPH-137 (30 and 80 mg/kg) had no effect on the infection process in Syrian hamsters. The comparison with the challenge control group showed that intraperitoneal RPH-137 (100 mg/kg) had statistically significant effects on a number of parameters, including a 27% reduction in inflammation and a 30% reduction in the total lesion area of the lungs by Day 7. Intragastric molnupiravir (300 mg/kg twice daily) significantly inhibited SARS-CoV-2 infection.Conclusions: both RPH-137 and molnupiravir inhibited the cytopathic effect of SARS-CoV-2 in Vero cells. In Syrian hamsters, molnupiravir demonstrated a more pronounced inhibition of SARS-CoV-2 infection than RPH-137. However, RPH-137 had statistically significant effects on a range of parameters. This offers additional perspectives for further research.
21 April 2025 in Genij Ortopedii
Introduction Replacement of bone defects is an important issue of modern traumatology and orthopedics. With increasing technological advances there is a spectrum of bone-substituting materials, and the choice of the effective option is essential for biomedical research.The objective was to determine the effect of the three-dimensional structure and pore size of tricalcium phosphate based bone substitute materials on osteoconduction using a critical diaphyseal defect of the rat femur.Material and methods A monocortical 7 mm defect was simulated in the middle third of the rodent femoral shaft under anaesthesia and filled with blocks of one of four tricalcium phosphate based materials differing in the number, size and direction of pores. Eight rats from each group were sacrificed at 3 and 6 months, and the newly formed bone was histologically examined and the results compared using statistical methods.Results The bone tissue was shown to grow into the defect area through the pores of the material in all the groups at 3 and 6 months, The newly formed bone measured (11 ± 4) % and (31 ± 6) % of the defect area in the Cylinders group, (14 ± 5) % and (29 ± 4) % in the Gyroid group; (39 ± 5) % and (41 ± 7) % in the Gyroid-150 μm group and (17 ± 7) % and (27 ± 8) % in the Gyroid-50 μm group, respectively. The area of newly formed bone was statistically greater in the Gyroid-150 µm group compared to that in the other groups (p < 0.05, Kruskal – Wallis test).Discussion The effect of the type of architecture of the bone substitute material, the pore size and their relationships are reported in many studies with larger diameter pores (more than 600 μm) improving osteoconduction, and the upper limit of porosity being limited by a decrease in the mechanical properties of the block. The advantages of the Gyroid structure over other types of architectures are described in theoretical and applied research. Structures with pores of different sizes were examined in few studies, and our findings demonstrated the feasibility of using the complex structures and the role in replacing bone tissue.Conclusion The three-dimensional structure of bone substitute materials based on tricalcium phosphate was shown to have an effect on osteoconductive properties, with an additional pore mode with a diameter of 150 μm added to the Gyroid structure leading to significantly greater experimental bone tissue ingrowth in the sample.